Sun Pharma tanks on USFDA observations on Halol plant

Sun Pharma announced on Tuesday the US drugs regulator, US Food and Drug Administration has issued a ‘Form 483’, after inspecting its Halol facility in Gujarat. The action led to a near 3% fall in the company’s scrip to close at Rs 861.60 on the BSE.